Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
Healthy Volunteers
NCT07563244

Computer-assisted Cognitive Stimulation Treatment for Delirium

Led by Institut Investigacio Sanitaria Pere Virgili · Updated on 2026-05-01

60

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

I

Institut Investigacio Sanitaria Pere Virgili

Lead Sponsor

I

Institut Pere Mata

Collaborating Sponsor

AI-Summary

What this Trial Is About

The objectives of our study are to determine whether people with delirium in a subacute care unit improve after one week with non-pharmacological therapies based on improving sleep schedules, mobility, and cognitive stimulation (such as memory, attention, orientation, among others), and to compare two groups of people who will receive slightly different therapies. We will try to determine whether individual characteristics (such as diagnosed diseases, blood test results or genetics, gender, age, educational level, among others) influence the onset of an episode of delirium, its severity and its response to treatment. Participants with delirium will be divided into two groups that will receive: * The non-pharmacological treatment described * One group will also receive a specific cognitive intervention from an occupational therapist, using a computer programme on a tablet, twice a day for one week. After one week, the presence and severity of delirium will be reassessed.

CONDITIONS

Official Title

Computer-assisted Cognitive Stimulation Treatment for Delirium

Who Can Participate

Age: 60Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 60 years or older
  • Admitted to the subacute care center between 15 February and 15 October 2026
  • Signed informed consent by the patient or legal guardian if the patient cannot consent
Not Eligible

You will not qualify if you...

  • Receiving palliative end-of-life care at admission
  • Under 60 years of age
  • Severe visual or hearing impairment or aphasia
  • Serious communication difficulties due to language

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut Pere Mata

Reus, Tarragona, Spain, 43206

Actively Recruiting

Loading map...

Research Team

E

Esteban Sepulveda-Ramos, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here